Cargando…
Identification of Additional Anti-Persister Activity against Borrelia burgdorferi from an FDA Drug Library
Lyme disease is a leading vector-borne disease in the United States. Although the majority of Lyme patients can be cured with standard 2–4 week antibiotic treatment, 10%–20% of patients continue to suffer from prolonged post-treatment Lyme disease syndrome (PTLDS). While the cause for this is unclea...
Autores principales: | Feng, Jie, Weitner, Megan, Shi, Wanliang, Zhang, Shuo, Sullivan, David, Zhang, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790293/ https://www.ncbi.nlm.nih.gov/pubmed/27025631 http://dx.doi.org/10.3390/antibiotics4030397 |
Ejemplares similares
-
Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library
por: Feng, Jie, et al.
Publicado: (2014) -
A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library
por: Feng, Jie, et al.
Publicado: (2016) -
Eradication of Biofilm-Like Microcolony Structures of Borrelia burgdorferi by Daunomycin and Daptomycin but not Mitomycin C in Combination with Doxycycline and Cefuroxime
por: Feng, Jie, et al.
Publicado: (2016) -
Persister mechanisms in Borrelia burgdorferi: implications for improved intervention
por: Feng, Jie, et al.
Publicado: (2015) -
Persister mechanisms in Borrelia burgdorferi: implications for improved intervention
por: Feng, Jie, et al.
Publicado: (2015)